The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeted therapies (TT) in metastatic renal cell carcinoma (mRCC): An Italian survey of 902 pts.
Felice Pasini
No relevant relationships to disclose
Anna Paola Fraccon
No relevant relationships to disclose
Carmen Barile
No relevant relationships to disclose
Cosimo Sacco
No relevant relationships to disclose
Teodoro Sava
No relevant relationships to disclose
Francesco Valduga
No relevant relationships to disclose
Umberto Basso
No relevant relationships to disclose
Emanuela Vattemi
No relevant relationships to disclose
Giovanni Rosti
No relevant relationships to disclose
Emilia Durante
No relevant relationships to disclose
Maurizio Nicodemo
No relevant relationships to disclose
Giovanni Lo Re
No relevant relationships to disclose
Rita Cengarle
No relevant relationships to disclose
Paola Bertocchi
No relevant relationships to disclose
Daniele Bernardi
No relevant relationships to disclose
Donata Sartori
No relevant relationships to disclose
Donatella Donati
No relevant relationships to disclose
Cristina Pegoraro
No relevant relationships to disclose
Alessandro Inno
No relevant relationships to disclose
Franco Bassan
No relevant relationships to disclose